Developing next gen. of point-of-care clinical Dx platform capable of identifying 24 genetic targets from a single test under 90 minutes
Founded in 2011, we've developed a POC multiplex system, called NEXD, which carries out entire mole. testing steps on a biochip: sample preparation, nucleic acid extraction, amplification, to detection/reporting. NEXD address 3 most significant challenges facing POC: 1) multiplexing--NEXD can detect 24 genetic targets in a test under 90 min.; 2) easy-of-use-NEXD can be used by anyone; 3) low cost- 50% cheaper than current systems on the market .